N-(4-((3-(trifluoromethyl)phenyl)sulfonyl)benzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide manufacturers
- GNE-618
-
- $178.00
-
2026-05-11
- CAS:1362151-42-5
- Purity:
- Supply Ability: 10g
|
| | N-(4-((3-(trifluoromethyl)phenyl)sulfonyl)benzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide Basic information |
| | N-(4-((3-(trifluoromethyl)phenyl)sulfonyl)benzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide Chemical Properties |
| Boiling point | 740.6±60.0 °C(Predicted) | | density | 1.479±0.06 g/cm3(Predicted) | | solubility | DMSO: Soluble | | form | Solid | | pka | 8.97±0.40(Predicted) | | color | Off-white to light yellow |
| | N-(4-((3-(trifluoromethyl)phenyl)sulfonyl)benzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide Usage And Synthesis |
| Description | GNE-618 is an inhibitor of nicotinamide phosphoribosyl transferase (NAMPT). | | Uses | GNE-618 is a potent, orally active nicotinamide phosphoribosyl transferase (NAMPT) inhibitor with an IC50 of 6 nM. GNE-618 depletes NAD levels and induces tumor cell death. Anti-tumor activity[1]. | | in vivo | GNE-618 (100 mg/kg; p.o.; twice daily for 5 days) significantly inhibits tumor growth by 88% and has minimal effects on body weight in STO#81 patient-derived gastric model[1]. | | References | [1] Xiao Y, et al. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway rendersthem sensitive to NAMPT inhibition with GNE-618. Neoplasia. 2013 Oct;15(10):1151-60. DOI:10.1593/neo.131304 [2] XIAOZHANG ZHENG . Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)[J]. Bioorganic & Medicinal Chemistry Letters, 2013, 23 20: Pages 5488-5497. DOI: 10.1016/j.bmcl.2013.08.074 |
| | N-(4-((3-(trifluoromethyl)phenyl)sulfonyl)benzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide Preparation Products And Raw materials |
|